Berkshire Hathaway buybacks hit $9.6 billion as Profit falls. Berkshire Hathaway repurchased $9.6 billion of its shares during the third quarter of 2026, even as operating earnings declined nearly 6% to $12.71 billion. Weaker insurance results overshadowed gains elsewhere in the conglomerate. Berkshire Hathaway buybacks surged to $9.6 billion in the third quarter of 2026, even as the company's operating Profit declined nearly 6%. The results, released Saturday, November 7, highlighted a shift toward more aggressive share repurchases under Chief Executive Greg Abel, alongside mounting pressure on Berkshire's insurance businesses. The Omaha, Nebraska-based conglomerate reported operating earnings of $12.71 billion, down from $13.49 billion a year earlier. Despite the decline, Berkshire continued directing substantial capital toward its own shares, bringing total repurchases during the first nine months of 2026 to approximately $14.4 billion. Berkshire Hathaway buybacks accelerate under Greg Abel. Berkshire's third-quarter repurchases were twice the approximately $4.8 billion spent during the first half of 2026. The company also purchased about $2 billion of additional shares during the first four weeks of October, extending its buyback activity beyond the reporting period. The increased spending marks an important development under Abel, who succeeded Warren Buffett as chief executive at the beginning of 2026. Buffett became increasingly selective about major acquisitions and share repurchases in his final years leading the company. Abel's approach suggests a greater willingness to deploy available capital when management considers Berkshire shares attractively valued. Share repurchases reduce the number of outstanding shares, potentially increasing existing investors' proportional ownership. However, their financial benefit depends on the price paid and whether that spending delivers better long-term returns than acquisitions or other investments. According to Berkshire's November 7 earnings release, approximately 1.419 million Class A equivalent shares remained outstanding at September 30. The company continued to maintain substantial financial resources despite its increased repurchase activity. Insurance weakness drives operating earnings lower. The decline in Berkshire's operating Profit was concentrated in its insurance operations. Underwriting earnings fell to $1.35 billion from $2.37 billion a year earlier, down about 43%. Insurance investment income also declined, falling to $2.73 billion from $3.18 billion. GEICO, Berkshire's major automobile insurer, faced pressure from higher claims costs and weaker underwriting performance. Insurance profitability depends on the relationship between premiums collected, claims paid and operating expenses. Rising claims expenses can significantly reduce earnings when premium increases fail to keep pace. The insurance downturn contrasted with stronger results from several of Berkshire's other major businesses. BNSF reported quarterly earnings of $1.73 billion, up from $1.45 billion a year earlier. Berkshire Hathaway Energy generated $1.61 billion, up from $1.49 billion. Manufacturing, service and retail operations also improved, contributing $4.04 billion against $3.62 billion in the previous year's quarter. These gains helped offset insurance losses but were insufficient to prevent the overall decline in operating earnings. Net Profit falls 28% as investment gains shrink. Berkshire's reported net income declined approximately 28% to $22.11 billion from $30.80 billion in the third quarter of 2025. The larger decrease reflected changes in investment gains, which fell to $9.41 billion from $17.31 billion. Unlike operating earnings, reported net income includes changes in the market value of Berkshire's stock investments, even when the company has not sold those holdings. These accounting adjustments can create significant fluctuations between reporting periods without corresponding changes in the performance of its underlying businesses. Berkshire has repeatedly cautioned investors against relying on quarterly investment gains and losses to evaluate its performance. Its operating earnings exclude those investment fluctuations and provide a separate view of results from insurance, railroads, energy and other businesses. Large cash reserves keep investment options open. Berkshire ended September with approximately $356.9 billion in cash and equivalents, according to its quarterly financial disclosures. These substantial reserves give management flexibility to pursue acquisitions, buy publicly traded securities, or continue repurchasing Berkshire shares. The company faces a different capital allocation challenge from technology businesses committing large portions of their operating cash to infrastructure expansion. As TechAmerica's analysis of Big Tech shareholder returns found, heavy artificial intelligence investment has reduced the funds several major technology companies have available for stock repurchases. For Berkshire, the immediate question is whether additional repurchases represent the most attractive use of its capital. Its considerable financial resources offer strategic flexibility, but large cash holdings can also weigh on investment returns when attractive opportunities remain limited. What investors will watch next. Berkshire's latest results reveal two separate trends: a more active share repurchase strategy and continued weakness in insurance profitability. Improved earnings from rail transportation, utilities, and manufacturing show the benefits of theconglomerate'ss diversified operations, but insurance remains a major source of earnings volatility. Investors will be watching whether Abel maintains the faster pace of buybacks and how effectively Berkshire manages its remaining cash. A recovery in insurance underwriting would also strengthen operating results, while sustained claims pressure could continue limiting earnings growth. The third-quarter figures show that Berkshire has considerable capacity to return capital to shareholders despite weaker operating Profit. Whether those repurchases create lasting value will depend on future business performance, Berkshire's share valuation and management's ability to identify attractive investments.

Berkshire Hathaway buys back $9.6 billion of its own stock but its profits declined. OMAHA, Neb. (AP) - Berkshire Hathaway repurchased $9.6 billion worth of its own shares in the third quarter, but Geico's numbers got worse as it invested more in ads and its overall profit fell more than 28% as the value of its investments changed. But the buybacks likely came to a halt recently as Berkshire's Class A stock price surged past $878,000 and topped where it was before Warren Buffett surprised investors with his plans to retire at the annual meeting in May 2025. He gave up the chairman title in September after relinquishing the CEO job to Greg Abel in January. Berkshire's massive cash pile also returned to growing in the third quarter and reached $377.4 billion, up from $365.5 billion at the end of June. CFRA Research analyst Cathy Seifert said Geico is in a tough spot right now with insurance premiums declining at the same time the average cost of the claims are increasing. Berkshire underwriting profit at all its insurers fell to $1.35 billion from last year's $2.37 billion. Geico accounted for most of that by generating $982 million this year, down from $1.77 billion a year ago. Investor Chris Ballard, who is managing director at Check Capital, said they were not disappointed in Geico's numbers because they reflect that the company is investing again in its iconic spokeslizard and trying to attract more customers. Getting more aggressive at writing new policies always tends to put pressure on an auto insurer's bottom line. "It should be looking better. Progressive is doing better, but they were doing so well for so long. They had cut their advertising for quite a while there," said Ballard, whose firm invested in Berkshire. "So we've been kind of expecting this on our end." Seifert said Berkshire's noninsurance businesses that Abel has overseen for years - such as manufacturers like Precision Castparts, the utilities and BNSF railroad - seem to be performing better than its massive insurance unit even with the lack of major hurricanes or other catastrophes this year. "I think we're seeing the businesses that play to Greg's strengths do well. But the question is what about the rest of the franchise," Seifert said. Berkshire reported a $22.1 billion profit, or $15,502 per Class A share, on Saturday morning. That's down from $30.8 billion, or $21,413 in last year's third quarter, but those bottom-line figures always tend to obscure how the dozens of companies the conglomerate owns are performing. The company has long recommended that investors pay more attention to operating earnings, which exclude the value of its investments that can vary widely, but those also slipped nearly 6% to $12.7 billion, or $8,907 per Class A share. That's down from $13.485 billion, or $9,376.15 per Class A share a year ago.

Case corner - Government Employees Insurance Co. v. Quality Spine Center, Inc., et al. Jurisdiction: U.S. District Court for the Southern District of Florida case no.: 9:26-cv-81439 date filed: October 23, 2026 presiding Judge: Ed Artau legal area: insurance fraud | Civil RICO | healthcare billing. GEICO files $4 million federal RICO lawsuit against South Florida medical clinics. In Government Employees Insurance Co. et al. v. Quality Spine Center, Inc., et al., GEICO and three affiliated insurance companies filed a federal lawsuit alleging that three South Florida healthcare clinics and four individuals participated in a fraudulent insurance billing scheme involving more than $4 million. The complaint, filed October 23, 2026, in the U.S. District Court for the Southern District of Florida, accuses the defendants of submitting thousands of improper personal injury protection (PIP) claims for chiropractic treatment, physical therapy, pain management, and diagnostic imaging services. GEICO alleges that the scheme began no later than 2021 and involved predetermined treatment protocols, repetitive diagnoses, and billing for medically unnecessary services or treatment that was not performed. The insurer seeks to recover more than $4 million and obtain a declaration that it has no obligation to pay more than $75,000 in additional disputed claims. The allegations have not been proven in court. The clinics and healthcare providers named in the lawsuit. The plaintiffs are Government Employees Insurance Company, GEICO Indemnity Company, GEICO General Insurance Company, and GEICO Casualty Company. The defendants include Quality Spine Center, Inc., located in Delray Beach; Atlas Medical and Orthopedics, LLC, located in Greenacres; and Palm Beach MRI LLC. Four individuals are also named: chiropractor Michael Brian Finkelstein, D.C.; M. Rahat Faderani, D.O.; Duclos Dessalines, M.D.; and Edvard Dessalines. According to GEICO, the defendants participated in a coordinated arrangement involving medical services and insurance claims associated with automobile accident patients. The insurer contends that the disputed billing was not the result of isolated errors but reflected a broader pattern of improper conduct. Allegations of unnecessary treatment and repetitive diagnoses. A central issue in the complaint involves the medical necessity of services provided to patients following automobile accidents. GEICO alleges that patients with different injuries frequently received similar diagnoses and were directed toward substantially similar treatment plans. The insurer claims the clinics used predetermined treatment protocols rather than consistently developing individualized treatment based on each patient's medical condition. The disputed services included chiropractic care, physical therapy, interventional pain management, and MRI examinations. According to the complaint, certain services were unnecessary, improperly billed, or not actually performed. GEICO also challenges the projected medical necessity of particular procedures, including injections and radiofrequency ablation. The allegations raise questions about whether the treatment was medically justified and whether the insurance submissions accurately represented the services provided. However, similar diagnoses or treatment plans do not independently establish fraud. The insurer must prove its allegations through evidence. The allegations involving Dr. M. Rahat Faderani. The lawsuit separately challenges the professional activities of Dr. M. Rahat Faderani. According to GEICO, the Florida Board of Osteopathic Medicine imposed permanent restrictions on Dr. Faderani in 2013 following disciplinary proceedings involving controlled substance prescribing. The insurer alleges that those restrictions prohibited him from owning, operating, or working in a pain management clinic. GEICO contends that Dr. Faderani violated those restrictions through his involvement with Atlas Medical and Orthopedics. Atlas disputes the allegations and has defended Dr. Faderani's medical license and the practice's compliance with applicable requirements. Whether the alleged conduct violated the restrictions remains a disputed issue. Why GEICO filed a federal RICO lawsuit. The complaint invokes 18 U.S.C. § 1962, part of the federal Racketeer Influenced and Corrupt Organizations Act. Civil RICO claims can arise when a plaintiff alleges a qualifying pattern of racketeering activity connected to an enterprise. In this case, GEICO contends that the defendants participated in a coordinated healthcare billing scheme involving repeated improper insurance submissions. The insurer is seeking relief beyond the denial of individual reimbursement requests. GEICO alleges that the defendants' activities formed part of a broader course of fraudulent conduct. However, filing a RICO lawsuit does not establish that a racketeering enterprise existed or that the defendants committed fraud. Those allegations must satisfy the applicable legal requirements. Atlas Medical and Orthopedics denies the allegations. Atlas Medical and Orthopedics has publicly challenged GEICO's accusations. In a statement reported by Becker's, the practice characterized the lawsuit as a "clawback attempt" by the insurer. Atlas denied having relationships with the other defendants beyond the referrals described in the complaint and stated that no one at its practice had met them. The clinic also defended its treatment documentation and billing practices, maintaining that its services were documented and its charges were consistent with community rates. According to Atlas, Dr. Faderani is also an active attorney practicing healthcare law and compliance. The practice further stated that it undergoes annual compliance inspections and is accredited by the Department of Health. Atlas said it looked forward to defending itself against the allegations. These statements reflect the practice's position in the dispute, not judicial findings. The federal court proceedings. GEICO filed its complaint on October 23, 2026. The federal docket identifies three accompanying exhibits described as RICO charts concerning Quality Spine Center, Atlas Medical and Orthopedics, and Palm Beach MRI. The case was assigned to Judge Ed Artau, and summonses were issued to the defendants. GEICO requested a jury trial. The lawsuit seeks recovery of more than $4 million in allegedly improper insurance payments and declaratory relief concerning more than $75,000 in additional disputed claims. The filing establishes that GEICO initiated the litigation, but it does not establish that the defendants are liable or that the insurer is entitled to recover the disputed amounts. Why this case matters for Florida insurance litigation. Government Employees Insurance Co. v. Quality Spine Center illustrates how disagreements over medical necessity and insurance billing can develop into federal litigation involving allegations of coordinated fraud. The case raises issues concerning treatment documentation, individualized medical care, professional licensing restrictions, and the accuracy of insurance reimbursement requests. For healthcare providers, the allegations underscore the importance of accurate records and compliance with applicable professional requirements. For insurers, the lawsuit illustrates the use of civil RICO claims to challenge what an insurer believes to be a broader pattern of fraudulent billing. The outcome will depend on whether GEICO can establish the alleged misconduct and satisfy the legal requirements of its claims. Case corner takeaway. GEICO's October 23, 2026 lawsuit accuses three South Florida healthcare clinics and four individuals of participating in an alleged insurance billing scheme involving more than $4 million. The insurer challenges repetitive diagnoses, allegedly unnecessary treatment, improper billing, and professional licensing compliance. Atlas Medical and Orthopedics has denied the allegations and defended its practices. The case remains a dispute over allegations, not a judicial determination of fraud. Its significance lies in the questions it raises about medical billing practices and the use of federal civil RICO litigation to challenge allegedly coordinated insurance claims. Today's insight. "Facts are stubborn things." - john adams. Allegations may initiate a lawsuit, but evidence determines whether those claims can be established in court.